A review of medical literature found that infections following epidural and spinal blocks are rare. Infections following peripheral nerve block catheters are more common but have been less frequently studied; this may necessitate a review of patient and procedural aspects to lower the risk associated with these procedures.
A study using lower limbs from two cadavers to demonstrate the technique of adductor canal (AC) block found that the needle trajectory of the traditional approach led to impalement of the nerve to vastus medialis (NVM) in 33% of cases and direct contact with the nerve in another 22%.
A new study led by researchers at The University of Texas MD Anderson Cancer Center discovered that co-occurring mutations in three tumor suppressor genes – KEAP1, SMARCA4 and CDKN2A – are linked with poor clinical outcomes in patients with KRAS G12C-mutant non-small cell lung cancer (NSCLC) treated with the KRAS G12C inhibitors adagrasib or sotorasib.
Using disinformation to create political instability and battlefield confusion dates back millennia. However, today’s disinformation actors use social media to amplify disinformation that users knowingly or, more often, unknowingly perpetuate. Such disinformation spreads quickly, threatening public health and safety. Indeed, the COVID-19 pandemic and recent global elections have given the world a front-row seat to this form of modern warfare.
Indiana University Melvin and Bren Simon Comprehensive Cancer Center served as the lead site for a promising first-in-human clinical trial for patients with relapsed multiple myeloma. Patients treated with higher doses of the immunotherapy called REGN5459 resulted in a 90.5 percent overall response rate.
New research presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (Copenhagen, 15-18 April) and published in The Lancet Public Health shows that the impact of COVID-19 on mortality in people living with intellectual disabilities extended beyond deaths from the virus itself, and was linked with increased mortality in several other conditions.
The CD70-targeting allogeneic chimeric antigen receptor (CAR) T cell therapy, ALLO-316, demonstrated encouraging response rates and disease control rates in patients with metastatic clear cell renal cell carcinoma (ccRCC), according to results of a Phase I trial led by researchers at The University of Texas MD Anderson Cancer Center and presented today at the American Association for Cancer Research (AACR) Annual Meeting 2023.
New, never before presented research will be shared during the 2023 American Association of Neurological Surgeons (AANS) Annual Scientific Meeting in Los Angeles. The late-breaking abstract “Efficacy and Safety of Early Minimally Invasive Removal of Intracerebral Hemorrhage (ENRICH): a Multicenter Randomized Adaptive Trial,” will be showcased during the Plenary Session l, Saturday, April 22, at 9:39 am- 9:49 am, PST.
ISPOR—The Professional Society for Health Economics and Outcomes Research announced the plenary sessions and speakers for its annual international conference, ISPOR 2023. The conference is scheduled for May 7-10 in Boston, MA, USA.
The first-in-class YAP/TEAD inhibitor VT3989 was well tolerated with durable antitumor responses in patients with advanced malignant mesothelioma and other tumors with NF2 mutations, according to results of a Phase I trial led by researchers at The University of Texas MD Anderson Cancer Center.
Results from a preclinical study from Penn Medicine, presented at the AACR Annual Meeting 2023, verified a new target for drug-resistant ovarian cancer and provided data to support a treatment approach that is already making its way into clinical trials.
A regimen of pre-surgical immunotherapy and chemotherapy followed by post-surgical immunotherapy significantly improved event-free survival (EFS) and pathologic complete response (pCR) rates compared to chemotherapy alone for patients with operable non-small cell lung cancer (NSCLC), according to Phase III trial results presented today by researchers from The University of Texas MD Anderson Cancer Center at the American Association for Cancer Research (AACR) Annual Meeting 2023.
Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce that Selwyn M. Vickers, MD, FACS, President and Chief Executive Officer of MSK, and Andrea Schietinger, PhD, Associate Member of the Immunology Program at the Sloan Kettering Institute, will be honored at the 2023 American Association for Cancer Research (AACR) Annual Meeting for their significant contributions to cancer research and care
Researchers from the Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania will present data on the latest advances across the full spectrum of cancer research at the American Association for Cancer Research (AACR) Annual Meeting 2023 from April 14-19 in Orlando, Florida.
A new study to be presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2023, Copenhagen 15-18 April), and published in The Lancet, shows that, compared with standard care that included low dose corticosteroid use, treating hypoxic COVID-19 patients needing only oxygen therapy or no breathing support with higher dose corticosteroids is associated with a 60% increased risk of death.
The American Association of Neurological Surgeons (AANS) Annual Meeting will be the first ever to showcase the late-breaking abstract “Decompressive Craniectomy vs Craniotomy for Traumatic Acute Subdural Hematoma” Sunday, April 23, at 9:10 am-9:18 am, during Plenary Session ll.
A new study sheds light on an understudied aspect of today’s opioid crisis: What happens to the cardiovascular health of babies exposed to opioids in the womb.
New smart-drug treatment options for pancreatic cancer, immuno-oncology treatments and real-time immune-monitoring strategies are among the research topics to be presented by investigators at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) at the American Association for Cancer Research (AACR) annual meeting held April 14-19 at the Orange County Convention Center in Orlando, Florida.
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. This special edition features presentations by MD Anderson researchers at the American Association for Cancer Research (AACR) Annual Meeting 2023.
American Cancer Society researchers are headed to Orlando, Florida this week for the annual meeting of the American Association of Cancer Research.
The NCCN 2023 Annual Conference took place in-person in Orlando and virtually, with a particular focus on human connection. That connection was underscored with more than 2,000 registrants from across the continuum of cancer care, including approximately 1,000 who returned in-person for the first time since 2019. Educational sessions highlighted the importance of ensuring care meets the latest standards while also rejecting a one-size-fits-all approach.
The American Association of Cancer Research (AACR) will honor two investigators from St. Jude Children’s Research Hospital for their research contributions. Melissa Hudson, M.D., director of the Cancer Survivorship Division and Jun J. Yang, Ph.D., vice-chair of Pharmacy and Pharmaceutical Sciences
Cedars-Sinai Cancer oncologists and researchers are available to comment on late-breaking topics and research throughout the American Association for Cancer Research (AACR) Annual Meeting 2023, happening April 14-19 in Orlando.
Complimentary press passes are now available for NUTRITION 2023, the annual flagship meeting of the American Society for Nutrition. Join us July 22-25 in Boston to hear about the latest developments in nutrition research, practice, and policy.
The American Association of Neurological Surgeons (AANS) Annual Meeting is known for showcasing the latest research, science and technology, and this year is no exception in Los Angeles. The late-breaking abstract “An Intracortical Speech BCI for High-Performance Brain-to-Text Communication” will be shared during the Opening Session, Friday, April 21, at 5:30 pm-5:38 pm, PST.
Yale Cancer Center (YCC) and Smilow Cancer Hospital (SCH) physicians and scientists are presenting research studies at the 2023 American Association for Cancer Research (AACR) Annual Meeting at the Orange County Convention Center in Orlando, Florida, April 14 to 19th.
A June 13-14 gathering of scientific and regulatory experts at the National Press Club
A new Cornell University-led study suggests that if artificial intelligence tools can counsel a doctor like a colleague – pointing out relevant research that supports the decision – then doctors can better weigh the merits of the recommendation.
A significant clinical trial under the direction of Michael Kappelman, MD, MPH, professor of pediatrics at UNC School of Medicine, found that patients receiving the tumor necrosis factor inhibitor adalimumab combined with a low dose of methotrexate, a second immunosuppressant, did better than those treated with infliximab alone. Patients who received infliximab, another tumor necrosis factor inhibitor, had similar outcomes with or without methotrexate.
20240326113011.png&width=400&height=400){kind=logo}
Imagine getting the benefits of gastric bypass surgery without going under the knife. A new class of potential treatments has done that in lab animals, reducing weight dramatically and lowering blood glucose without side effects, scientists report. They will present their results at ACS Spring 2023.
Recordings of media briefings will be posted by 10 a.m. Eastern Time on each day. Watch recorded media briefings at: www.acs.org/ACSSpring2023briefings.
The fruit of the cocklebur plant, which grows worldwide and is often considered a noxious weed, has antioxidant and anti-inflammatory components that could make it useful as a skin protectant, according to new research.
A new study has revealed insights into how cells sense and respond to the weightlessness experienced in space. The information could be useful for keeping astronauts healthy on future space missions.
New research has revealed important information about how aspirin works. The new findings could pave the way to safer aspirin alternatives and might also have implications for improving cancer immunotherapies.
Cedars-Sinai and BlackDoctor.org will host a virtual community conversation about the importance of increasing diverse representation in medical research.
Scientists report using a single-atom-thick nanomaterial to build a device that can simultaneously detect the presence of the viruses that cause COVID-19 and the flu — at much lower levels and much more quickly than conventional tests for either. They will present their results at ACS Spring 2023.
Naloxone can reverse potentially fatal overdoses, but it’s less effective against powerful fentanyl. To develop alternatives, researchers are looking to a component of marijuana, CBD. They will present their results at ACS Spring 2023.
Growing concerns over the potential health effects of exposure to phthalates have led to a search for safer alternatives. Researchers found that the chemical acetyl tributyl citrate (ATBC) might not be the best replacement.
A new study found that people who are currently suffering or face a high risk of post-traumatic stress disorder show particular patterns in four biomarkers measurable with a simple blood test.
For the first time, researchers have developed a form of the omega-3 fatty acid docosahexaenoic acid (DHA) that is capable of crossing into the eye’s retina to ward off visual declines related to Alzheimer’s disease, diabetes and other disorders.
The results of two clinical trials, presented today at the Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on Women’s Cancer, showcased adding immunotherapy to standard chemotherapy resulted in significantly longer progression-free survival (PFS) among patients with advanced or recurrent endometrial cancer (EC).
In an effort to improve understanding of pulmonary fibrosis (PF) and interstitial lung disease (ILD), data from the PFF Registry is presenting researchers with opportunities to accelerate understanding of PF and ILD to improve patient outcomes.
Needles are an uncomfortable but necessary aspect of vaccination. But today, scientists report steps toward an alternative, relatively painless method that can deliver biological materials to cells by “shooting” them in with air. They will present their results at ACS Spring 2023.
Researchers examined how a country’s number of published 3D protein structures for coronaviruses correlated with its economic output and population. The findings reveal important insights into how different countries' research establishments respond to disease outbreaks.
After resolving missing data burdens, the ENGOT-OV16/NOVA (NCT01847274) study data shows no difference in overall survival for platinum-sensitive recurrent ovarian cancer (PSROC) patients who received PARP inhibitor niraparib maintenance therapy (MT) and those who did not. Results from the trial were presented today at the Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on Women’s Cancer by Ursula Matulonis, MD, of the Dana-Farber Cancer Institute.
A new study identified a compound that prevents C. diff infection. Researchers are now using this compound to develop new drug candidates that might eventually offer a way to prevent serious C. diff infections.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
